FDA Inspection
Resilience Biotechnologies, Inc.Resilience Biotechnologies, Inc. – FDA Inspection, Nov 10, 2023
Record Details
This FDA Inspection record concerns Resilience Biotechnologies, Inc., with an inspection on November 10, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 05467109-0e4f-47bb-b291-c9dd62aa3478
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1222580
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Resilience Biotechnologies, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2018 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
| February 3, 2017 | Not classified | Office of Inspections and Investigations | |
| July 26, 2013 | OAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
| July 17, 2012 | OAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
Other documents for Resilience Biotechnologies, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.